These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19953621)

  • 1. Reexamining the treatment of advanced laryngeal cancer: the VA laryngeal cancer study revisited.
    Wolf GT
    Head Neck; 2010 Jan; 32(1):7-14. PubMed ID: 19953621
    [No Abstract]   [Full Text] [Related]  

  • 2. Reexamining the treatment of advanced laryngeal cancer.
    Olsen KD
    Head Neck; 2010 Jan; 32(1):1-7. PubMed ID: 19953627
    [No Abstract]   [Full Text] [Related]  

  • 3. Larynx preservation and survival trends: should there be concern?
    Forastiere AA
    Head Neck; 2010 Jan; 32(1):14-7. PubMed ID: 19953631
    [No Abstract]   [Full Text] [Related]  

  • 4. Searching for less toxic larynx preservation: a need for common definitions and metrics.
    Forastiere AA; Trotti AM
    J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative assessment of the five-year results of surgical, combined, radiation and chemoradiotherapy in laryngeal cancer (T3N0M0)].
    Tkachëv SI; Matiakin EG; Liubaev VL; Boĭkov VP; Alieva SB; Aliev BM; Kondrat'eva AP; Aketova TA; Pirogova NA; Loginova IN
    Vopr Onkol; 2006; 52(4):404-7. PubMed ID: 17024811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
    Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
    J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ preservation for advanced laryngeal carcinoma.
    Foote RL; Foote RT; Brown PD; Garces YI; Okuno SH; Strome SE
    Head Neck; 2006 Aug; 28(8):689-96. PubMed ID: 16619278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined modality treatment of laryngeal squamous cell carcinoma.
    Devlin JG; Langer CJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):331-50. PubMed ID: 17338653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ preservation surgery for laryngeal cancer.
    Tufano RP; Stafford EM
    Otolaryngol Clin North Am; 2008 Aug; 41(4):741-55, vi. PubMed ID: 18570956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ preservation therapy for advanced-stage laryngeal carcinoma.
    Hoffman HT; McCulloch T; Gustin D; Karnell LH
    Otolaryngol Clin North Am; 1997 Feb; 30(1):113-30. PubMed ID: 8995140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of T1-T2 glottic carcinomas.
    Mendenhall WM; Werning JW; Hinerman RW; Amdur RJ; Villaret DB
    Cancer; 2004 May; 100(9):1786-92. PubMed ID: 15112257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based practice: management of glottic cancer.
    Hartl DM
    Otolaryngol Clin North Am; 2012 Oct; 45(5):1143-61. PubMed ID: 22980690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
    ; Pfister DG; Laurie SA; Weinstein GS; Mendenhall WM; Adelstein DJ; Ang KK; Clayman GL; Fisher SG; Forastiere AA; Harrison LB; Lefebvre JL; Leupold N; List MA; O'Malley BO; Patel S; Posner MR; Schwartz MA; Wolf GT
    J Clin Oncol; 2006 Aug; 24(22):3693-704. PubMed ID: 16832122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy for larynx preservation: patient selection or therapeutic effect?
    Pfister DG; Ridge JA
    J Clin Oncol; 2006 Feb; 24(4):540-3. PubMed ID: 16380409
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group.
    Hillman RE; Walsh MJ; Wolf GT; Fisher SG; Hong WK
    Ann Otol Rhinol Laryngol Suppl; 1998 May; 172():1-27. PubMed ID: 9597955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemoradiation therapy in conjunction with physical means of radiomodification for locally advanced laryngeal cancer].
    Pankratov VA; Andreev VG; Rozhov VA; Gulibov IA; Baryshev VV; Buiakova ME; Vdovina SN; Kurpeshev OK; Podlesnykh NI; Litovkina LV
    Vopr Onkol; 2006; 52(2):200-2. PubMed ID: 17195649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laryngeal neoplasms].
    Mozet C; Dietz A
    Laryngorhinootologie; 2010 May; 89(5):295-315. PubMed ID: 20458662
    [No Abstract]   [Full Text] [Related]  

  • 19. Organ preservation in head and neck cancer: are there reliable molecular predictors?
    Hanna EY
    Curr Oncol Rep; 2001 Jan; 3(1):43-4. PubMed ID: 11123868
    [No Abstract]   [Full Text] [Related]  

  • 20. Laryngeal pleomorphic rhabdomyosarcoma.
    Schrock A; Jakob M; Zhou H; Bootz F
    Auris Nasus Larynx; 2007 Dec; 34(4):553-6. PubMed ID: 17481838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.